Abstract:Objective The association of high-sensivity C-reactive protein (hs-CRP) on patients undergoing percutaneous coronary intervention (PCI) and the long-term prognostic value were evaluated.Methods A prospective cohort study was prospectively conducted in 287 consecutive patients who were hospitalized in the Department of Cardiology of Shanghai Zhongshan Hospital undergoing primary PCI between Dec.2007 and Dec.2008.Levels of hs-CRP and other cardiovascular risk factors were determined before PCI.The patients were followed up for a mean of 54 months.Their cardiovascular end points were recorded.Results The mean value of serum hs-CRP in patients with cardiovascular disease (CVD) readmission and death was significantly higher than those without CVD readmission and death (2.21 mg/L versus 1.10 mg/L,Z=-3.152;6.60 mg/L versus 1.22 mg/L,Z=-3.192;P both ＜0.05).The cardiac troponin T,WBC,multivessel disease,stent placement and the low HDL-C are the factors relating to serum hs-CRP levels.The coefficients of correlation have statistical significance (t =8.575,4.763 and -2.770;P ＜0.05).The odd ratios for CVD readmissiom and CVD death were 1.714(95％ CI,1.164-2.523)and 5.023 (95 ％ CI,2.003-12.600).Kaplan-Meier survival analysis demonstrated a significantly reduced 5-year readmission rate in patients with 3.65 ＜ hs-CRP ≤ 82.51 mg/L [43.75％ (30/71) groups versus the lower hs-CRP level groups(20.83％,15/72) ; x2 =10.375,P ＜ 0.001by Log-rank].The same as the death rate [9.86％ (7/71) were evaluated in the lower hs-CRP level groups (1.38％,1/72) ;x2 =11.362,P ＜0.05 by Log-rank].The readmission rate and mortality in the patients with hs-CRP ＞3.0 mg/ L are 43.75％ (35/80)and 8.75％ (7/80),respectively.The survival time was all less than 20 months.Conclusions The results demonstrated that hs-CRP is an independent risk factor in cardiovascular disease.High hs-CRP is strongly associated with 5-year occurance of readmission and death for cardiovascular events.Hs-CRP can be a strong indicator of risk stratification and prognostic evaluation on cardiovascular high-risk populations.

C-reactive Protein-to-serum Albumin Ratio As a Novel Predictor of Long-Term Outcomes in Coronary Artery Disease Patients Who Have Undergone Percutaneous Coronary Intervention: Analysis of a Real-World Retrospective Cohort Study

Prognostic value of C-reactive protein to albumin ratio for mortality in acute kidney injury

C-reactive Protein/Albumin Ratio As a Prognostic Indicator in Posttraumatic Shock and Outcome of Multiple Trauma Patients

The Association Between High-Sensitivity C-Reactive Protein/Albumin Ratio and Cardiovascular Prognosis in Patients Undergoing Percutaneous Coronary Intervention

Prognostic Value of Preoperative High-Sensitivity C-reactive Protein to Albumin Ratio in Patients with Dilated Cardiomyopathy Receiving Pacemaker Therapy: A Retrospective Two-Center Study in China

Predictive Value of Baseline C-reactive Protein for Periprocedural Myocardial Infraction of Higher Risk Stratifications: A Retrospective Cohort Clinical Study

Postoperative Ratio of C-Reactive Protein to Albumin As a Predictive Marker in Patients with Crohn’s Disease Undergoing Bowel Resection

Monocyte-to-serum albumin Ratio as a Novel Predictor of Long-Term Adverse Outcomes in Patients after Undergoing Percutaneous Coronary Intervention: A Retrospective Cohort Study

Preoperative C-reactive protein/albumin ratio and mortality of off-pump coronary artery bypass graft

High-sensitivity C-reactive protein to high-density lipoprotein cholesterol ratio predicts long-term adverse outcomes in patients who underwent percutaneous coronary intervention: A prospective cohort study

Association between the C-reactive protein to albumin ratio and poor clinical outcome in patients with spontaneous intracerebral hemorrhage

Association between C-Reactive Protein to Albumin Ratio and Multi-Vessel Coronary Artery Disease in Patients with Stable Coronary Artery Disease

Preoperative C-reactive Protein/albumin Ratio to Predict Mortality and Recurrence of Patients with Hepatocellular Carcinoma after Curative Resection.

Renal Dysfunction and hsCRP Predict Long-term Outcomes of Percutaneous Coronary Intervention in Acute Myocardial Infarction.

C-reactive Protein and Other Cardiovascular Biomarkers Are Prediction of Long-Term Outcomes in Patients Undergoing Percutaneous Coronary Intervention

The relationship between C-reactive protein/albumin ratio and mortality in hypertensive patients: a national cohort study

Predictive values of C-reactive protein/albumin ratio in new-onset atrial fibrillation after coronary artery bypass grafting.

Relationship Between High Sensitivity C-reactive Protein to Albumin Ratio With Infarct-related Artery Patency in Patients With Non-ST-segment Elevation Myocardial Infarction

Monocyte-to-albumin ratio as a novel predictor of long-term adverse outcomes in patients after percutaneous coronary intervention

C-reactive protein to albumin ratio may predict in-hospital mortality in non-ST elevation myocardial infarction

High C-Reactive Protein/ Albumin Ratio Predicts Mortality and Hemorrhage in Stroke Patients Undergoing Mechanical Thrombectomy: A Systematic Review and Meta-Analysis